These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31028990)
61. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953 [TBL] [Abstract][Full Text] [Related]
62. Design, Synthesis, and Evaluation of Alkyl-Quinoxalin-2(1 Blöcher R; Rodarte Ramírez A; Castro-Escarpulli G; Curiel-Quesada E; Reyes-Arellano A Molecules; 2018 Nov; 23(12):. PubMed ID: 30477243 [TBL] [Abstract][Full Text] [Related]
63. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET). Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016 [TBL] [Abstract][Full Text] [Related]
64. Palladium(II)-catalyzed oxidative arylation of quinoxalin-2(1H)-ones with arylboronic acids. Carrër A; Brion JD; Messaoudi S; Alami M Org Lett; 2013 Nov; 15(21):5606-9. PubMed ID: 24117215 [TBL] [Abstract][Full Text] [Related]
65. Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives. Guillon J; Cohen A; Gueddouda NM; Das RN; Moreau S; Ronga L; Savrimoutou S; Basmaciyan L; Monnier A; Monget M; Rubio S; Garnerin T; Azas N; Mergny JL; Mullié C; Sonnet P J Enzyme Inhib Med Chem; 2017 Dec; 32(1):547-563. PubMed ID: 28114821 [TBL] [Abstract][Full Text] [Related]
66. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives. Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736 [TBL] [Abstract][Full Text] [Related]
67. Emergence of pyrido quinoxalines as new family of antimalarial agents. Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715 [TBL] [Abstract][Full Text] [Related]
68. Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure. Kawanishi N; Sugimoto T; Shibata J; Nakamura K; Masutani K; Ikuta M; Hirai H Bioorg Med Chem Lett; 2006 Oct; 16(19):5122-6. PubMed ID: 16876403 [TBL] [Abstract][Full Text] [Related]
69. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150 [TBL] [Abstract][Full Text] [Related]
70. Copper-catalyzed cascade syntheses of 2H-benzo[b][1,4]thiazin-3(4H)-ones and quinoxalin-2(1H)-ones through capturing S and N atom respectively from AcSH and TsNH(2). Chen D; Wang ZJ; Bao W J Org Chem; 2010 Aug; 75(16):5768-71. PubMed ID: 20666413 [TBL] [Abstract][Full Text] [Related]
71. Microwave-Assisted Multicomponent Synthesis of Dihydroquinoxalinones on Soluble Polymer Support. Dalvi PB; Lin SF; Paike V; Sun CM ACS Comb Sci; 2015 Jul; 17(7):421-5. PubMed ID: 26101959 [TBL] [Abstract][Full Text] [Related]
72. Photoinduced ligand to metal charge transfer enabling cerium mediated decarboxylative alkylation of quinoxalin-2(1 Singh S; Dagar N; Roy SR Chem Commun (Camb); 2022 Mar; 58(23):3831-3834. PubMed ID: 35234798 [TBL] [Abstract][Full Text] [Related]
73. Efficient, Mg(2+)-dependent photochemical DNA cleavage by the antitumor quinobenzoxazine (S)-A-62176. Yu H; Kwok Y; Hurley LH; Kerwin SM Biochemistry; 2000 Aug; 39(33):10236-46. PubMed ID: 10956013 [TBL] [Abstract][Full Text] [Related]
74. Rejuvenating the [1, 2, 3]-triazolo [1,5-a]quinoxalin-4(5 Pelliccia S; Alfano AI; Gomes Da Assunção BR; Turco L; Lembo F; Summa V; Buommino E; Brindisi M Front Chem; 2023; 11():1126427. PubMed ID: 36998572 [TBL] [Abstract][Full Text] [Related]
75. Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold. Vernall AJ; Stoddart LA; Briddon SJ; Hill SJ; Kellam B J Med Chem; 2012 Feb; 55(4):1771-82. PubMed ID: 22277057 [TBL] [Abstract][Full Text] [Related]
76. Facile, eco-friendly, catalyst-free synthesis of polyfunctionalized quinoxalines. Zhang Y; Luo M; Li Y; Wang H; Ren X; Qi C Mol Divers; 2018 Feb; 22(1):183-189. PubMed ID: 28980110 [TBL] [Abstract][Full Text] [Related]